Vermox Dosing for a 20.4 kg Child
For a 20.4 kg child, administer one single 500 mg mebendazole (Vermox) chewable tablet as a single dose, chewed completely before swallowing. 1
Dosing Rationale
The FDA-approved dosing for Vermox is not weight-based for the treatment of common intestinal helminth infections (roundworm and whipworm). The standard dose is:
- One 500 mg chewable tablet as a single dose for patients ≥1 year of age 1
- The tablet must be chewed completely before swallowing; do not swallow whole 1
This single-dose regimen applies regardless of the child's weight, making it straightforward for a 20.4 kg child who is over 1 year of age.
Important Administration Details
For children who cannot chew the tablet:
- The tablet can be crushed and mixed with food if the child has difficulty chewing 1
- Administration with food may increase bioavailability, and clinical studies in pediatric patients typically administered the medication with food 1
Indication-Specific Considerations
The 500 mg single-dose regimen is specifically approved for:
- Ascaris lumbricoides (roundworm)
- Trichuris trichiura (whipworm) 1
For other helminth infections requiring different dosing:
- Whipworm (heavy infections): May require 100 mg twice daily in combination with ivermectin for improved cure rates 2
- Hookworm: The single 500 mg dose is less effective than for Ascaris; consider albendazole 400 mg daily for 3 days as an alternative 2
- Threadworm (Enterobius): Typically requires 100 mg as a single dose, which may need repeating 2
Safety Considerations
Key warnings for this age group:
- Mebendazole is contraindicated in infants <1 year due to risk of convulsions 1
- At standard doses (500 mg single dose), the drug is well-tolerated with minimal side effects 1, 3
- Avoid concomitant use with metronidazole due to risk of Stevens-Johnson syndrome/toxic epidermal necrolysis 1
Monitoring is generally not required for single-dose therapy at standard doses. However, if prolonged or high-dose therapy is needed (e.g., for tissue infections like echinococcosis at 100-200 mg/kg/day), monitor complete blood counts for neutropenia/agranulocytosis 1, 4
Clinical Pearls
- The 500 mg chewable formulation has been validated for acceptability in children aged 2-4 years and is considerably better accepted than conventional tablets 5
- Younger children (ages 1-3 years) have higher systemic exposure than adults, but this does not require dose adjustment for standard single-dose therapy 1
- For mixed nematode infections, the single 500 mg dose provides excellent efficacy against Ascaris (>95% reduction in egg output) but may be less effective against Trichuris and hookworm 3